PG-1012528

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePG-1012528
Drug Alias Name7iLck inhibitors (P&G)Lck inhibitors (Procter & Gamble)Lck inhibitor (Procter & Gamble)Lck inhibitors (P&G) +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase LCK inhibitors
TargetsTyrosine-protein kinase LCK
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProcter & Gamble Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProcter & Gamble Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A